Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Plos One|February 4, 2017
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.International Journal of Clinical Oncology|August 13, 2013
Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes regionPierre Etienne Heudel, Philippe Cousin, Antoine Lurkin, et al.Scientific Reports|October 21, 2025
Multimodal prediction of metastatic relapse using federated deep learning in soft-tissue sarcoma with a complex genomic profileCharles Maussion, Jean-Michel Coindre, Jean-Yves Blay, et al.Journal of Personalized Medicine|April 23, 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2016
Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma GroupJacques Fourquet, Marie-Pierre Sunyach, Florent Vilotte, et al.BMC Medicine|April 11, 2017
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational studyMarion Savina, Axel Le Cesne, Jean-Yves Blay, et al.Annals of Surgical Oncology|August 17, 2022
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary CentersFulvio Borella, Stefano Cosma, Domenico Ferraioli, et al.Annals of Surgical Oncology|July 25, 2019
Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation RateGauthier Decanter, Eberhard Stoeckle, Charles Honore, et al.European Journal of Cancer Care|September 7, 2020
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes regionDomenico Ferraioli, Olivia Bally, Pierre Meeus, et al.Oncotarget|August 29, 2015
The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic valueXiaojun Jiang, Daniel Pissaloux, Christelle De La Fouchardiere, et al.Pageof 9